Genocea Biosciences Closes IPO

(RTTNews) - Genocea Biosciences, Inc. (GNCA) said Monday that it has closed its initial public offering of 5.5 million shares of its common stock at a public offering price of $12.00 per share.

After underwriting discounts and commissions and estimated offering expenses, Genocea received net proceeds of about $61.4 million, excluding estimated offering expenses.

The company's shares are listed on the NASDAQ Global Market.

Citigroup and Cowen and Company are acting as joint book-running managers for the offering. Stifel is acting as lead manager and Needham & Company, LLC is acting as co-manager.